Delirium is a neuropsychiatric complication that can occur in patients with cancer, particularly in those with advanced disease. The prevention of delirium in the patient with cancer has not been systematically examined, but studies in hospitalized elderly patients suggest that early identification of risk factors reduces the occurrence rate of delirium and the duration of episodes.
Delirium has been defined as a disorder of global cerebral dysfunction characterized by disordered awareness, attention, and cognition. In addition, delirium is associated with behavioral manifestations. The text revision of the fourth edition of the Diagnostic and Statistical Manual for Mental Disorders (DSM-IV-TR) cites the core clinical criteria for diagnosis as follows:
This complementary and alternative medicine (CAM) information summary provides an overview of the use of hydrazine sulfate as a treatment for people with cancer. The summary includes a brief history of hydrazine sulfate research, results of clinical trials, and possible side effects of hydrazine sulfate use.
This summary contains the following key information:
Hydrazine sulfate is a chemical that has been studied as a treatment for cancer and as a treatment for the body wasting (i.e., cachexia)...
A disturbance of consciousness with reduced clarity of awareness and attention deficit.
Other cognitive or perceptual disturbances.
Acuity of onset (hours to days) and fluctuation over the course of the day.
The presence of an underlying cause such as a general medical condition (e.g., hypoxia or electrolyte disturbance), medication, a combination of etiologies, or indeterminate etiology.
Other associated noncore clinical criteria features include sleep-wake cycle disturbance, delusions, emotional lability, and disturbance of psychomotor activity. The latter forms the basis of classifying delirium into three different subtypes:[4,5]
Mixed, with both hypoactive and hyperactive features.
In this summary, unless otherwise stated, evidence and practice issues as they relate to adults are discussed. The evidence and application to practice related to children may differ significantly from information related to adults. When specific information about the care of children is available, it is summarized under its own heading.
Inouye SK, Bogardus ST Jr, Charpentier PA, et al.: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340 (9): 669-76, 1999.
Lipowski ZJ: Delirium in the elderly patient. N Engl J Med 320 (9): 578-82, 1989.
American Psychiatric Association.: Delirium, dementia, and amnestic and other cognitive disorders. In: American Psychiatric Association.: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th rev. ed. Washington, DC: American Psychiatric Association, 2000, pp 135-80.
Clinical features, course, and outcome. In: Lipowski ZJ: Delirium: Acute Confusional States. New York, NY: Oxford University Press, 1990, pp 54-70.
Camus V, Burtin B, Simeone I, et al.: Factor analysis supports the evidence of existing hyperactive and hypoactive subtypes of delirium. Int J Geriatr Psychiatry 15 (4): 313-6, 2000.
In this article
This information is produced and provided by the National
Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National
Institute via the Internet web site at http://
.gov or call 1-800-4-CANCER.
WebMD Public Information from the National Cancer Institute
September 04, 2014
This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this